Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib with Chemoradiation for Larynx/Hypopharynx Cancer
NCT00498953Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- May 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in laryngeal squamous cell carcinoma (LSCC), hypopharyngeal squamous cell carcinoma (HSCC), sponsored by European Organisation for Research and Treatment of Cancer. Started May 2007; status: completed.
02
Drugs
lapatinib
03
Conditions
laryngeal squamous cell carcinoma (LSCC)hypopharyngeal squamous cell carcinoma (HSCC)
Beyond the preview
Go deeper on NCT00498953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498953.